The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Improving patient survival with the colorectal cancer multi‐disciplinary team
Abstract
Objective There is little information on the impact of the colorectal multi‐disciplinary team (MDT) in the United Kingdom. Our single operator presented his patients before and after the inception of an MDT meeting in June 2002. The aim of this study was to assess the effect of this on his patients’ survival, and trends in the use of adjuvant chemotherapy. Method Data were collected on all patients (n = 310) undergoing colectomy for colorectal cancer by one surgeon. Excluding patients with Dukes A stage, the pre‐MDT cohort from January 1997 to May 2002 was 176 and the post‐MDT cohort from June 2002 to December 2005 was 134. Three‐year survival rates were calculated using Kaplan–Meier life table analysis. Prognostic factors were analysed using Cox‐proportional hazard regression, and chemotherapy data analysed using the chi‐squared test. Independent prognostic indicators of chemotherapy prescription were examined using binary logistic testing. Results MDT status was shown to be an independent predictor of survival on hazard regression analysis (P = 0.044). A significantly greater number of patients were prescribed adjuvant chemotherapy in the post‐MDT cohort (P = 0.0002). MDT status was shown to be a significant prognostic indicator of chemotherapy prescription (P < 0.0001). Three‐year survival for Dukes C patients was 58% in the pre‐MDT group, and 66% in the post‐MDT group (P = 0.023). Conclusion There was a significant increase in patients undergoing adjuvant postoperative chemotherapy after the inception of the MDT. This was associated with a significant survival benefit in patients with Dukes C disease. The data suggest that the MDT process has resulted in an increase in the prescription of adjuvant chemotherapy, with 3‐year survival being greater after its inception.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Cited by
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Pillay, B., Wootten, A. C., Crowe, H., Corcoran, N., Tran, B., Bowden, P., Crowe, J., & Costello, A. J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.007 · Cited by 704
Adam, R., De Gramont, A., Figueras, J., Guthrie, A., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0121 · Cited by 583
The multidisciplinary management of rectal cancer
Keller, D. S., Berho, M., Perez, R. O., Wexner, S. D., & Chand, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0275-y · Cited by 359
Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer
Bruheim, K., Guren, M. G., Skovlund, E., Hjermstad, M. J., Dahl, O., Frykholm, G., Carlsen, E., & Tveit, K. M. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.010 · Cited by 278
Metadata
- Authors
- MacDermid, E., Hooton, G., MacDonald, M., McKay, G., Grose, D., Mohammed, N., & Porteous, C.
- Venue
- Colorectal Disease
- Publisher
- Wiley
- Published
- 2009-02-13
- Volume
- 11
- Issue
- 3
- Pages
- 291-295
- ISSN
- 1462-8910 (ISSN-L)
- 1463-1318
- OpenAlex
- W2091598002
- Cited by
- 214
- References
- 1
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving patient survival with the colorectal cancer multi‐disciplinary team. https://app.cochat.ai/papers/10.1111/j.1463-1318.2008.01580.x
- The paper
- MacDermid, E., Hooton, G., MacDonald, M., McKay, G., Grose, D., Mohammed, N., & Porteous, C. (2009). Improving patient survival with the colorectal cancer multi‐disciplinary team. Colorectal Disease. https://doi.org/10.1111/j.1463-1318.2008.01580.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.